A great opportunity to advance preclinical drug development for AD/ADRD research! Xona is actively looking for partners interested in screening/validating their target compound(s) using our cell-based tau mislocalization assay or similar assays for Alzheimer’s Disease (AD/ADRD) research. We have high content imaging capabilities and are planning to use 3D human iPSC-derived neuron cultures.
We are applying for a NIH/NIA SBIR for this development work, so this is a wonderful chance to explore project feasibility without commitments.
Please contact us at email@example.com to learn more.
To learn more about products and research services provided by Xona, please contact us at firstname.lastname@example.org.